Abbott expands Ensure shakes line
ABBOTT PARK, Ill. Abbott on Thursday introduced two new nutrition shakes — Ensure Muscle Health and Ensure Clinical Strength — both formulated to help rebuild muscle mass naturally lost with age.
Ensure Muscle Health shakes contain Abbott’s proprietary ingredient, Revigor, a source of HMB (beta-hydroxy-beta-methylbutyrate, an amino-acid metabolite), and 13 g of protein.
“Abbott scientists have been studying muscle loss for more than a decade,” stated Rob Miller, divisional VP global research and development and scientific affairs. “We’ve taken our expertise with HMB, the ingredient that has been clinically shown to support muscle mass and functionality in healthy, exercising adults, and have added it to one of our therapeutic nutrition products for people over 40 who are naturally losing muscle with age.”
Ensure Clinical Strength shakes offer focused clinical nutrition, coupling the benefits of Revigor and protein with Immune Balance, a unique blend of prebiotic fiber to support digestive tract health and antioxidants to support the immune system.
Clinical research has shown that beginning around 40 years of age, people can start to lose 8% of muscle mass per decade, which can lead to loss of strength and mobility. Weakness, fatigue, low energy and weight loss are signals of muscle loss.
In addition to two new innovative nutrition shakes, Abbott recently relaunched its product line and introduced a new, streamlined look for the Ensure brand. With an updated logo and packaging, it is easier for consumers to find the Ensure shake to fit their nutritional needs, whether it’s Ensure Muscle Health, Ensure Clinical Strength, Ensure Immune Health, Ensure Bone Health, Ensure or Ensure Plus.
FDA advisory committees forgo restricting cough-cold sales, CHPA responds
WASHINGTON A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the FDA not place greater sales restrictions on the sale of dextromethorphan by placing the ingredient on the controlled substances schedule. The panel of FDA advisers voted to not schedule DXM by a vote of 15-9.
"Today’s FDA advisory committee decision not to recommend scheduling [over-the-counter] cough medicines containing dextromethorphan as a controlled substance reflects a sound balancing of the benefits of over-the-counter medicines containing dextromethorphan,” the Consumer Healthcare Products Association stated in a release following the decision. “Because of cough’s widespread prevalence and effects, it’s vital for people to have OTC access to safe and effective self-treatment. Dextromethorphan is in nearly 90% of OTC cough suppressants sold today,” the statement read.
"We do, however, recognize the need for continued education to keep any abuse levels low,” the CHPA added. “We also have long called for federal legislation that would limit purchases of bulk quantities of dextromethorphan to manufacturers who are registered with FDA. We believe that a statutory ban on sales of dextromethorphan medicines to those under 18 [years of age] would limit abuse.”
H.D. Smith signs prime vendor agreement with U.S.-based Nigerian pharmacy group
CINCINNATI and SPRINGFIELD, Ill. A large group of Nigerian-owned independent retailers has struck a new, three-year prime vendor agreement with H.D. Smith, a leading national pharmaceutical wholesaler.
H.D. Smith and the Nigerian Association of Pharmacists and Pharmaceutical Scientists in America said the deal would bolster both groups. Under terms of the contract, H.D. Smith will become the primary supplier of pharmaceutical products for the more than 100 U.S. pharmacies that are NAPPSA members. The supply agreement begins immediately and extends through June 30, 2013.
“We are excited and proud of this accomplishment, and hope it is only the beginning of more to come,” said NAPPSA Nnodum Iheme. “Since success breeds success, we anticipate more Nigerian-owned pharmacies to join or partner with NAPPSA.”
H.D. Smith chairman and CEO Dale Smith also expressed satisfaction with the agreement. “The decision to select a primary vendor does not come lightly and demands close inspection of services, programs and reputation,” Smith said. “We seek to enhance NAPPSA members’ success.”
NAPPSA is an umbrella organization of Nigerian pharmacists, pharmaceutical scientists, allied scientists and academics in the Americas. “Among other objectives, NAPPSA fosters cooperative efforts among relevant educational, research, industrial, commercial and governmental entities; propagates critical information in the medical, biological, pharmaceutical and related healthcare-technology fields, for the optimization of health outcomes,” the group noted in a statement.
H.D. Smith markets itself as “the largest privately held national full-line, full-service wholesaler that provides a complete line of pharmaceuticals, OTCs, HBAs, home healthcare products, durable medical equipment, seasonal merchandise and a wide array of marketing programs to retail pharmacies, regional chains and health systems.”